Adenovirus-mediated wild-type-p53-gene expression sensitizes TNF- resistant tumor cells to TNF-induced cytotoxicity by altering the cellular- redox state

International Journal of Cancer

Volumn 85, Issue 1, 2000, Pages 93-97

  Shatrov, Vladimir A ^a   Ameyar, Maya ^a   Bouquet, Céline ^a   Cai, Zhenzi ^a   Stancou, Rodica ^a   Haddada, Hedi ^a   Chouaib, Salem ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ARTICLE; CELL DEATH; CELL VIABILITY; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; VIRUS PARTICLE; VIRUS RECOMBINANT;

ACETYLCYSTEINE; ADENOVIRIDAE; BREAST NEOPLASMS; CYTOPATHOGENIC EFFECT, VIRAL; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; GENETIC VECTORS; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033990967     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000101)85:1<93::AID-IJC17>3.0.CO;2-I     Document Type: Article

References (21)

1. BUCKBINDER, L., TALBOTT, R., VELASCOMIGUEL, S., TAKENAKA, I., FAHA, B., SEIZINGER, B.R. and KLEY, N., Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature (Lond.), 377, 646-649 (1995).
2. CAI, Z., CAPOULADE, C., MOYRET-LALLE, C., AMOR-GUERET, M., FEUNTEUN, J., LARSEN, A.K., BRESSAC-DE PAILLERETS, B. and CHOUAIB, S., Resistance of MCF7 human breast-carcinoma cells to TNF-induced cell death is associated with loss of p53 function. Oncogene, 15, 2817-2826 (1997).
3. COSSARIZZA, A., FRANCESCHI, C., MONTI, D., SALVIOLI, S., BELLESIA, E., RIVABENE, R., BIONDO, L., RAINALDI, G., TINARI, A. and MALORNI, W., Protective effect of N-acetylcysteine in tumor-necrosis-factor-α-induced apoptosis in U937 cells: the role of mitochondria. Exp. Cell Res., 220, 232-240 (1995).
4. ECK, H.P., GMUNDER, H., HARTMANN, M., PETZOLDT, D., DANIEL, V. and DRÖGE, W., Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol. Chem., 370, 101-108 (1989).
5. ISRAELI, D., TESSLER, E., HAUPT, Y., ELKELES, A., WILDER, S., AMSON, R., TELERMAN, A. and OREN, M. A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose over-expression promotes apoptosis. EMBO J., 16, 4384-4392 (1997).
6. KNUDSON, C.M., TUNG, K.S., TOURTELLOTTE, W.G., BROWN, G.A. and KORSMEYER, S.J., bax-deficient mice with lymphoid hyperplasia and male germ-cell death. Science, 270, 96-99 (1995).
7. KROEMER, G., PETIT, P., ZAMZAMI, N., VAYSSIERE, J.L. and MIGNOTTE, B., The biochemistry of programmed cell death. FASEB J., 13, 1277-1287 (1995).
8. LANG, D., MIKNYOCZKI, S.J., HUANG, L. and RUGGERI, B., Stable reintroduction of wild-type p53 (MTmp53ts) causes the induction of apoptosis and neuro-endocrine-like differentiation in human ductal pancreatic-carcinoma cells. Oncogene, 16, 1593-1602 (1998).
9. LIU, M., PELLING, J.C., JU, J., CHU, E. and BRASH, D.E., Anti-oxidant action via p53-mediated apoptosis. Cancer Res., 58, 1723-1729 (1998).
10. LOWE, S.W., BODIS, S., MCCLATCHEY, A., REMINGTON, L., RULEY, H.E., FISHER, D.E., HOUSMAN, D.E. and JACKS, T., p53 status and the efficacy of cancer therapy in vivo. Science, 266, 807-810 (1994).
11. LOWE, S.W., RULEY, H.E., JACKS. T. and HOUSMAN, D.E., p53-dependent apoptosis modulates the cytotoxicity of anti-cancer agents. Cell, 74, 957-967 (1993).
12. MANNA, S.K., ZHANG, H.J., YAN, T., OBERLEY, L.W. and AGGARWAL, B.B., Over-expression of manganese superoxide dismutase suppresses tumor-necrosis-factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activated protein-1. J. biol. Chem., 273, 13245-13254 (1998).
13. MIYASHITA, T. and REED, J.C., Tumor-suppressor p53 is a direct transcriptional activator of the human box gene. Cell, 80, 293-299 (1995).
14. OGRETMEN, B. and SAFA, A.R., Expression of the mutated p53 tumor-suppressor protein and its molecular and biochemical characterization in multidrug-resistant MCF-7/Adr human breast-cancer cells. Oncogene, 14, 499-506 (1997).
15. OREN, M. and PROVES, C., p53: upstream, downstream and off stream. Biochim. biophys. Acta. 1288, 13-19 (1996).
16. OWEN-SCHAUB, L.B., ZHANG, W., CUSACK, J.C., ANGELO, L.S., SANTEE, S.M., FUJIMARA, T., ROTH, J.A., DEISSEROTH, A.B., KRUZEL, E. and RADINSKY, R., Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. cell. Biol., 15, 3032-3040 (1995).
17. POLYAK, K., XIA, Y., ZWEIER, J.L., KINZLER, K.W. and VOGELSTEIN, B., A model for p53-induced apoptosis. Nature (Lond.,) 389, 300-305 (1997).
18. SCHULZE-OSTHOFF, K., BAKKER, A.C., VANHAESEBROECK, B., BEYART, R., JACOB, W.A. and FIERS, W., Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J. biol. Chem., 267, 5317-5323 (1992).
19. WOLD, W.S., Adenovirus genes that modulate the sensitivity of virus-infected cells to lysis by TNF. J. cell. Biochem., 53, 329-335 (1993).
20. WONG, G.H., ELWELL, J.H., OBERLEY, L.W. and GOEDDEL, D.V., Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell, 58, 923-931 (1989).
21. ZYAD, A., BENARD, J., TURSZ, T., CLARKE, R. and CHOUAIB, S., Resistance to TNF-alpha and adriamycin in the human breast-cancer MCF-7 cell line: relationship to MDR1, MnSOD and TNF gene expression. Cancer Res., 54, 825-831 (1994).